Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healing II: Complications

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The role of UV-induced cutaneous matrix metalloproteinases and mi-RNAs in the pathogenesis of lupus erythematosus.

Journal of translational autoimmunity·2025

Same author

Association of polymorphous light eruption with NOD-2 and TLR-5 gene polymorphisms.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Same author

[Photodynamic therapy-trends and new developments].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2020

Same author

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications - field cancerization, photorejuvenation and inflammatory/infective dermatoses.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Same author

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Same author

Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue

Published on: July 28, 2023

[Therapy of keloids].

¹Klinik und Poliklinik für Dermatologie, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93042 Regensburg. sigrid.karrer@klinik.uni-regensburg.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete

|October 12, 2007

Summary

Keloids are benign fibrous growths that extend beyond wounds. Current keloid treatments present challenges, with no single effective approach lacking side effects, necessitating further research.

Area of Science:

Dermatology
Pathology

Background:

Keloids are benign fibrous growths arising from skin injury or microtrauma.
They are distinct from hypertrophic scars, characterized by extending beyond wound margins and lack of spontaneous regression.
Keloids can cause significant cosmetic and functional issues, often accompanied by itching and pain.

Purpose of the Study:

To summarize current keloid treatment methods.
To outline the advantages and disadvantages of various therapeutic options for keloids.

Main Methods:

Review of existing literature on keloid treatment modalities.
Analysis of the efficacy and side effect profiles of different interventions.

Main Results:

Multiple treatment options for keloids exist, but none are consistently effective with minimal side effects.

More Related Videos

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jul 11, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue

Published on: July 28, 2023

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

Published on: November 29, 2024

High-quality research evaluating keloid therapies is limited.

Keloid management remains a significant challenge for dermatologists.

Conclusions:

There is a need for more robust research into keloid treatment.
Developing a reliably effective and safe keloid therapy is an ongoing challenge.